Pathalys Pharma is a private biopharmaceutical company focused on the late-stage development of innovative treatments for kidney disease. The company is advancing its lead product, upacicalcet, towards NDA submission and pre-commercialization, aiming to address unmet medical needs in nephrology.
Leadership & Board
Current Number of Employees18
Current LinkedIn Followers1,546
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$105M
Total Amount Raised$105M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$105M
Latest Funding Amount$105M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Pathalys Pharma had 18 employees as of September 7, 2026. The number of employees increased by 0 (0.00%) week-over-week.
18Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Pathalys Pharma had 1,546 followers as of September 7, 2026. The number of followers increased by 9 (0.59%) week-over-week.
1,546Latest Followers Count
9(0.59%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.